Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 9,291	$ 13,523
Prepaid expenses and other current assets	1,273	2,265
Other receivables	744	3,363
Total current assets	11,308	19,151
Restricted cash	5,480	5,720
Property and equipment, net	13,241	12,559
Operating lease right-of-use asset	41,687	44,717
In-process research and development	10,256	10,256
Goodwill	3,490	3,490
Other assets	975	2,470
Total assets	86,437	98,363
Current liabilities
Accounts payable and accrued liabilities	2,055	5,689
Accrued compensation	2,280	768
Term debt, current	38,954
Current portion of operating lease liabilities	4,431	9,481
Other current liabilities	529	523
Total current liabilities	48,249	16,461
Convertible Loan, non-current	32,897	58,633
Term debt, non-current	22,539	23,674
Operating lease liabilities, net of current portion	27,694	28,583
Deferred tax liability	3,077	3,077
Total liabilities	134,456	130,428
Commitments and contingencies (Note 12)
Stockholders' deficit
Common Stock, $0.01 par value; 217,000,000 shares authorized; 36,183,067 and 36,122,932 shares issued and outstanding at December 31, 2024 and December 31, 2023, respectively	362	361
Additional paid-in capital	279,354	276,393
Accumulated deficit	(327,735)	(308,819)
Total stockholders' deficit	(48,019)	(32,065)
Total liabilities and stockholders' deficit	$ 86,437	$ 98,363